Licia Rivoltini
0000-0002-2409-6225
Publication & Citation Trends
Publications
0 total
Efficacy of liver transplantation after response to atezolizumab-bevacizumab downstaging of intermediate and advanced hepatocellular carcinoma (ImmunoXXL).
Cited by 0
Semantic Scholar
775 Tumor and Immune Dynamics in BCG-Treated Non-Muscle Invasive Bladder Cancer: an Explorative Study
Cited by 0
Semantic Scholar
Immunomonitoring of patients with hepatic cancer undergoing liver transplantation after immunotherapy unravels an unexpected synergism between trained immunity and T cell memory. OA
Cited by 0
Semantic Scholar
OS-062 Liver transplantation after downstaging of intermediate and advanced HCC with atezolizumab-bevacizumab: a prospective study (ImmunoXXL)
Cited by 1
Semantic Scholar
2641P Systemic immunosuppressive and pro-inflammatory milieu associates with poor prognosis and resistance to therapy in metastatic Collecting Duct (CDC) carcinoma patients
Cited by 0
Semantic Scholar
P466: Antitumor immunological benefits of Vitamin E analogue δ-tocotrienol in early breast cancer patients depend on body mass index: results from the TOCANNATO window-of-opportunity trial OA
Cited by 0
Semantic Scholar
THU-454 Induction of systemic immune activation by liver transplant and effects of previous VEGF/PD-L1 blockade in HCC patients
Cited by 0
Semantic Scholar
1901P Specific dynamic changes of peripheral blood immune profile (PBIP) associate with clinical response to nivolumab (NIVO) in patients (pts) with metastatic renal cell carcinoma (mRCC): The I-RENE trial (meet-URO 8)
Cited by 0
Semantic Scholar
Research Topics
Immunotherapy and Immune Responses
(199)
Cancer Immunotherapy and Biomarkers
(157)
CAR-T cell therapy research
(100)
Immune Cell Function and Interaction
(76)
T-cell and B-cell Immunology
(45)
Affiliations
University of Siena
University of Verona
University of Copenhagen
National Institutes of Health
Radboud University Nijmegen